Skip to content

Clinical trials

Phase 1/2 Leukemia, Lymphocytic, Chronic, B-Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1/2 Country / region: Canada Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20051
20081
20091
20142
20152
20172
20181
20191
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sunnybrook Health Sciences Centre2
Accenture1
Aegera Therapeutics1
Allogene Therapeutics1
AstraZeneca1
BeOne Medicines1
Bristol-Myers Squibb1
Genentech, Inc.1
Genmab1
German CLL Study Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell16
Lymphoma, Non-Hodgkin6
Leukemia5
Lymphoma4
Recurrence4
Hematologic Neoplasms3
Hodgkin Disease2
Lymphoma, B-Cell2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Follicular2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.